Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Progressive Nuero
AddedFeb 19, 2024
UpdatedJun 18, 2026
Progressive Nuero

Progressive Nuero

Seed

Progressive Neuro, Inc: Innovating stroke treatment with unique, expedited pain relief devices.

HQ
Santa Clara, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Progressive Neuro, Inc., founded under the incubation of Silicon Prairie Center, is committed to revolutionizing stroke treatment. The company's core mission is to develop innovative ischemic stroke devices that offer physicians advanced treatment options beyond traditional methods like aspiration and thrombectomy. Progressive Neuro's vision is to expedite pain relief and improve patient outcomes through state-of-the-art medical technology.

Notable figures associated with Progressive Neuro include key medical device innovators and investors from the Silicon Prairie Center. The company has achieved significant milestones in developing a unique portfolio of stroke solutions, positioning itself as a leader in the medical device industry. Its impact is marked by providing next-generation treatment options that enhance the capabilities of healthcare providers and improve patient care in the realm of ischemic stroke.

Progressive Nuero - Similar Companies

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

Neurolutions logo

Neurolutions

neurolutions.com

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Cognition Medical logo

Cognition Medical

Epic Neuro logo

Epic Neuro

Rapidpulse logo

Rapidpulse

rapidpulsemed.com

Insera Therapeutics logo

Insera Therapeutics

Nervive logo

Nervive

NeuroBionics logo

NeuroBionics

Penumbra logo

Penumbra

penumbrainc.com

NeuroSave logo

NeuroSave

MindRhythm logo

MindRhythm

mindrhythm.com

StrokeDx logo

StrokeDx

stroke-dx.com

Route 92 Medical logo

Route 92 Medical

r92m.com

NeuroVasc Technologies logo

NeuroVasc Technologies

Progressive Nuero - Quick Facts

Who are Progressive Nuero's competitors?

Companies similar to Progressive Nuero include Mivi Neuroscience, Neurolutions, NeuRx Medical and Cognition Medical.

When was Progressive Nuero founded?

Progressive Nuero was founded in 2018.

Where is Progressive Nuero's headquarters located?

Progressive Nuero's headquarters is located in Santa Clara, CA, US.

When was Progressive Nuero's last funding round?

Progressive Nuero's most recent funding round was for $200k (USD) in August 2020.

How much has Progressive Nuero raised to-date?

As of Aug 19, 2020, Progressive Nuero has raised a total of $350k (USD).

How many employees does Progressive Nuero have?

Progressive Nuero has 5 employees as of Feb 4, 2024.

Progressive Nuero - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified